Business
Modular Medical Announces Proposed Public Offering
SAN DIEGO, CA / ACCESS Newswire / December 9, 2025 / Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical"), an insulin delivery technology company with the
About this update from Modular Medical, Inc.
[{"type":"text","content":"SAN DIEGO, CA / ACCESS Newswire / December 9, 2025 / Modular Medical, Inc. (NASDAQ:MODD) (\"Modular Medical\"), an insulin delivery technology company with the first FDA-cleared patch pump designed specifically to target all adult \"almost-pumpers\" with its user-friendly and affordable design, today announced that it has commenced an underwritten public offering (the \"offering\") of shares of its common stock and warrants to purchase shares of its common stock. The shares of the common stock and the accompanying warrants are immediately separable and will be issued separately but can only be purchased together in this offering.Modular Medical expects to grant the underwriter a 30-day option to purchase up to an additional 15% of the aggregate number of shares of its common stock and /or warrants sold in the offering. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed or as to the actual size or terms of the offering. All shares of common stock and warrants to be sold in the proposed offering will be sold by Modular Medical.Newbridge Securities Corporation is acting as the sole bookrunner for the proposed offering.The offering is being made pursuant to an effective \"shelf\" registration statement on Form S-3 (File No. 333-287313) previously filed with the Securities and Exchange Commission (the \"SEC\") on May 15, 2025 and declared effective by the SEC on May 22, 2025. The securities may be offered only by means of a prospectus. A preliminary prospectus supplement and the accompanying prospectus relating to and describing the terms of the offering will be filed with the SEC. Electronic copies of the preliminary prospectus supplement and accompanying prospectus and, when available, copies of the final prospectus supplement and the accompanying prospectus relating to the offering may be obtained by visiting the SEC's website at www.sec.gov or by contacting Newbridge Securities Corporation, Attn: Equity Syndicate Department, 1200 North Federal Highway, Suite 400, Boca Raton, Florida 33432, by email at [email protected] or by telephone at (877) 447-9625.This press release does not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or ot...